Cite
Aspirin ameliorates pulmonary vascular remodeling in pulmonary hypertension by dampening endothelial-to-mesenchymal transition.
MLA
Huang, Ning, et al. “Aspirin Ameliorates Pulmonary Vascular Remodeling in Pulmonary Hypertension by Dampening Endothelial-to-Mesenchymal Transition.” European Journal of Pharmacology, vol. 908, Oct. 2021, p. N.PAG. EBSCOhost, https://doi.org/10.1016/j.ejphar.2021.174307.
APA
Huang, N., Zhu, T.-T., Liu, T., Ge, X.-Y., Wang, D., Liu, H., Zhu, G.-X., Zhang, Z., & Hu, C.-P. (2021). Aspirin ameliorates pulmonary vascular remodeling in pulmonary hypertension by dampening endothelial-to-mesenchymal transition. European Journal of Pharmacology, 908, N.PAG. https://doi.org/10.1016/j.ejphar.2021.174307
Chicago
Huang, Ning, Tian-Tian Zhu, Ting Liu, Xiao-Yue Ge, Di Wang, Hong Liu, Guang-Xuan Zhu, Zheng Zhang, and Chang-Ping Hu. 2021. “Aspirin Ameliorates Pulmonary Vascular Remodeling in Pulmonary Hypertension by Dampening Endothelial-to-Mesenchymal Transition.” European Journal of Pharmacology 908 (October): N.PAG. doi:10.1016/j.ejphar.2021.174307.